Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2491 AL 2505

Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement-the Mobilise-D study protocol

Mikolaizak AS, Rochester L, Maetzler W, Sharrack B, Demeyer H, Mazzà C, Caulfield B, Garcia-Aymerich J, Vereijken B, Arnera V, Miller R, Piraino P, Ammour N, Gordon MF, Troosters T, Yarnall AJ, Alcock L, Gaßner H, Winkler J, Klucken J, Schlenstedt C, Watz H, Kirsten AM, Vogiatzis I, Chynkiamis N, Hume E, Megaritis D, Nieuwboer A, Ginis P, Buckley E, Brittain G, Comi G, Leocani L, Helbostad JL, Johnsen LG, Taraldsen K, Blain H, Driss V, Frei A, Puhan MA, Polhemus A, Bosch de Basea M, Gimeno E, Hopkinson NS, Buttery SC, Hausdorff JM, Mirelman A, Evers J, Neatrour I, Singleton D, Schwickert L, Becker C, Jansen CP; clinical validation study (WP4) on behalf of Mobilise-D consortium.

PLoS One. 2022 Oct 6;17(10):e0269615. doi: 10.1371/journal.pone.0269615. eCollection 2022.

Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial

Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C, McKee KE, Goelz L, Poon C, Tilley B, Kang UJ, Tansey MG, Luthra N, Tanner CM, Haus JM, Fantuzzi G, McFarland NR, Gonzalez-Latapi P, Foroud T, Motl R, Schwarzschild MA, Simuni T, Marek K, Naito A, Lungu C, Corcos DM; SPARX3-PSG Investigators.

Trials. 2022 Oct 6;23(1):855. doi: 10.1186/s13063-022-06703-0.

Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson's disease

Turski P, Chaberska I, Szukało P, Pyska P, Milanowski Ł, Szlufik S, Figura M, Hoffman-Zacharska D, Siuda J, Koziorowski D.

Front Neurosci. 2022 Sep 20;16:971270. doi: 10.3389/fnins.2022.971270. eCollection 2022.

Magnetic resonance imaging of the dopamine system in schizophrenia - A scoping review

Schulz J, Zimmermann J, Sorg C, Menegaux A, Brandl F.

Front Psychiatry. 2022 Sep 20;13:925476. doi: 10.3389/fpsyt.2022.925476. eCollection 2022.

Exploring the feasibility of technological visuo-cognitive training in Parkinson's: Study protocol for a pilot randomised controlled trial

Das J, Morris R, Barry G, Vitorio R, Oman P, McDonald C, Walker R, Stuart S.

PLoS One. 2022 Oct 7;17(10):e0275738. doi: 10.1371/journal.pone.0275738. eCollection 2022.

Impact of Covid-19 on research and training in Parkinson's disease

Wan YM, van Wamelen DJ, Lau YH, Rota S, Tan EK.

Int Rev Neurobiol. 2022;165:283-305. doi: 10.1016/bs.irn.2022.04.003. Epub 2022 May 4.

The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases

DeMaio A, Mehrotra S, Sambamurti K, Husain S.

J Neuroinflammation. 2022 Oct 8;19(1):251. doi: 10.1186/s12974-022-02605-9.

Effectiveness of electrical vestibular nerve stimulation on the range of motion in patients with Parkinson's disease

Kumar Goothy SS, Gawarikar S, Choudhary A, Govind PG, Purohit M, Pathak A, Chouhan RS, Ali Z, Tiwari M, Khanderao MV.

J Basic Clin Physiol Pharmacol. 2022 Oct 10;34(6):791-795. doi: 10.1515/jbcpp-2022-0138. eCollection 2023 Nov 1.

Deep Brain Stimulation in the Treatment of Parkinson's Disease

Shah H, Usman O, Ur Rehman H, Jhaveri S, Avanthika C, Hussain K, Islam H, I S K S.

Cureus. 2022 Sep 3;14(9):e28760. doi: 10.7759/cureus.28760. eCollection 2022 Sep.

Perry Syndrome with a Novel Mutation and a Rare Presentation: First Report from India

Krishnan P, Sarma GRK, Murgod U, Srinivas M, Roy AK.

Ann Indian Acad Neurol. 2022 Jul-Aug;25(4):703-706. doi: 10.4103/aian.aian_890_21. Epub 2022 Jun 21.

An update on advanced therapies for Parkinson's disease: From gene therapy to neuromodulation

Serva SN, Bernstein J, Thompson JA, Kern DS, Ojemann SG.

Front Surg. 2022 Sep 23;9:863921. doi: 10.3389/fsurg.2022.863921. eCollection 2022.

Tremor in Parkinson's Disease: From Pathophysiology to Advanced Therapies

Abusrair AH, Elsekaily W, Bohlega S.

Tremor Other Hyperkinet Mov (N Y). 2022 Sep 13;12:29. doi: 10.5334/tohm.712. eCollection 2022.

The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases

Huang B, Zhenxin Y, Chen S, Tan Z, Zong Z, Zhang H, Xiong X.

Oxid Med Cell Longev. 2022 Sep 28;2022:1315248. doi: 10.1155/2022/1315248. eCollection 2022.

Effects of choline containing phospholipids on the neurovascular unit: A review

Roy P, Tomassoni D, Nittari G, Traini E, Amenta F.

Front Cell Neurosci. 2022 Sep 23;16:988759. doi: 10.3389/fncel.2022.988759. eCollection 2022.

Applications and challenges of rhodopsin-based optogenetics in biomedicine

Zhang H, Fang H, Liu D, Zhang Y, Adu-Amankwaah J, Yuan J, Tan R, Zhu J.

Front Neurosci. 2022 Sep 23;16:966772. doi: 10.3389/fnins.2022.966772. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias